Dual X-ray absorptiometry detects disease- and treatment-related alterations of bone density in prostate cancer patients

Clinical and Experimental Metastasis

Volumn 18, Issue 5, 2000, Pages 385-390

  Smith, Gillian L ^a   Doherty, Alan P ^a   Banks, Linda M ^a   Dutton, Jane ^a   Hanham, Iain W ^a   Christmas, Timothy J ^a   Epstein, Richard J ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b DIVISION OF MEDICAL ONCOLOGY   (Singapore)

Author keywords

Bone density; Bone metastasis; Dual X ray absorptiometry; Prostate specific antigen; Prostatic neoplasms

Indexed keywords

ANTIANDROGEN; ANTINEOPLASTIC AGENT; BICALUTAMIDE; GONADORELIN;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE METASTASIS; BONE MINERAL; BONE SCINTISCANNING; CANCER CHEMOTHERAPY; CANCER GROWTH; CLINICAL ARTICLE; DISEASE COURSE; DUAL ENERGY X RAY ABSORPTIOMETRY; HUMAN; MALE; PROSTATE CANCER; TREATMENT OUTCOME;

ADULT; AGED; BONE DENSITY; BONE NEOPLASMS; BREAST NEOPLASMS; DENSITOMETRY, X-RAY; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS;

EID: 0034950165     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1010991213842     Document Type: Article

References (32)

1. Incidence and sites of bone lesions detected by 99mTc-polyphosphate scans in patients with tumors
2. Events in the natural history of prostate cancer: Using salvage curves, mean age distributions and contingency coefficients
3. Assessment of response to therapy in advanced breast cancer
4. Evaluation of bone disease in breast cancer
5. Urinary, excretion of deoxypyridinoline in patients with breast cancer
6. Bone loss induced by cancer treatment and its management
7. Growth factors in bone matrix. Isolation of multiple types of affinity chromatography on heparin sepharose
8. Reduction in new metastases in breast cancer with adjuvant clodronate treatment
9. Osteoporosis as a complication of orchiectomy in 2 elderly men with prostatic cancer
10. Bone fractures associated with luteinizing hormone-releasing hormone agonists used in the treatment of prostate carcinoma
11. Bone mineral density after adjuvant chemotherapy for premenopausal breast cancer
12. Effect of tamoxifen on bone mineral density measured by dual energy X-ray absorptiometry in healthy premenopausal and postmenopausal women
13. Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer
14. Introduction to bone biology
15. Dual energy X-ray absorptiometry (DXA)
16. Bone mineral density measured by dual energy X-ray absorptiometry in normal men
17. Bone mineral density and biochemical markers of bone turnover in healthy elderly men and women
18. The association between age and bone mineral density in men and women aged 55 years and over. The Rotterdam study
19. Assessment of response to therapy in advanced breast cancer
20. Monitoring therapeutic response in skeletal metastases using dual-energy X-ray absorptiometry: A prospective feasability study in breast cancer patients
21. 'Casodex' may preserve bone mineral density of patients with advanced prostate cancer
22. Immediate versus deferred treatment for advanced prostate cancer: Initial results of the Medical Research Council trial
23. Post-therapy serum prostate-specific antigen level and survival in patients with androgen-independent prostate cancer
24. Small cell and anaplastic prostate cancer: Correlation between CT findings and prostate-specific antigen level
25. Prognostic significance of extent of disease in bone in patients with androgen-independent prostate cancer
26. The flare phenomenon on radionuclide bone scan in metastatic prostate cancer
27. The assessment of response to therapy of bone metastases in breast cancer
28. The bone scan flare following systemic treatment for bone metastases
29. Vertebral compression fractures: A distinction between benign and malignant causes with MR imaging
30. Magnetic resonance imaging in the detection of skeletal metastases in patients with breast cancer
31. Monitoring of bone metastases